First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis
Author:
Funder
American College of Gastroenterology
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference36 articles.
1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng;Lancet,2018
2. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review;Fumery;Clin Gastroenterol Hepatol,2018
3. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy;Vester-Andersen;Am J Gastroenterol,2014
4. Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis;Bonovas;Aliment Pharmacol Ther,2018
5. Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis;Singh;Aliment Pharmacol Ther,2018
Cited by 263 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis;International Immunopharmacology;2024-10
2. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management;World Journal of Gastroenterology;2024-09-21
3. Prophylactic Effects of Betaine on Depression and Anxiety Behaviors in Mice with Dextran Sulfate Sodium-Induced Colitis;Journal of Agricultural and Food Chemistry;2024-09-14
4. Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-09-09
5. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study;Biomedicines;2024-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3